Literature DB >> 20045403

Decrease in antioxidant status of plasma and erythrocytes from patients with ankylosing spondylitis.

Agata Stanek1, Grzegorz Cieślar, Ewa Romuk, Sławomir Kasperczyk, Karolina Sieroń-Stołtny, Ewa Birkner, Aleksander Sieroń.   

Abstract

OBJECTIVES: The aim of the study was to evaluate the antioxidant status in plasma and erythrocytes from patients with ankylosing spondylitis (AS).
METHODS: 16 patients with AS and 16 healthy volunteers were involved in this study. Activities of antioxidant enzymes: superoxide dismutase (SOD) and its isoenzymes - (SOD-Mn) and (SOD-ZnCu), catalase (CAT), glutathione peroxidase (GPx), glutathione reductase (GR) and glutathione transferase (GST), as well as the total antioxidant status (TAS) and concentration of malondialdehyde (MDA) in plasma and/or erythrocytes, respectively were determined.
RESULTS: In patients with AS, a statistically significant decrease in plasma activity of SOD, SOD-CuZn and TAS, significant drop in activity of SOD, GPx, GST and GR in erythrocytes, as well as increased concentration of MDA in comparison with control group of healthy volunteers was observed.
CONCLUSION: Decrease in antioxidant status leading to generation of oxidative stress may play an important role in the pathogenesis of ankylosing spondylitis. Copyright 2009. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20045403     DOI: 10.1016/j.clinbiochem.2009.12.019

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  11 in total

1.  Evaluation of paraoxonase and arylesterase activities in Egyptian patients with ankylosing spondylitis.

Authors:  Shereem Mohamed Olama; Mohammed Mohamed Elarman
Journal:  Rheumatol Int       Date:  2012-12-14       Impact factor: 2.631

2.  Predictive value of microRNA-132 and its target gene NAG-1 in evaluating therapeutic efficacy of non-steroidal anti-inflammatory drugs treatment in patients with ankylosing spondylitis.

Authors:  Tuan-Mao Guo; Yong Yan; Wei-Ning Cao; Qiang Liu; Hai-Yun Zhu; Lan Yang; Mai-Cang Gao; Yan-Li Xing
Journal:  Clin Rheumatol       Date:  2018-03-01       Impact factor: 2.980

3.  Association of GSTM1, GSTT1, GSTP1-ILE105VAL and ACE I/D polymorphisms with ankylosing spondylitis.

Authors:  Esra Erkol İnal; Orhan Görükmez; Selma Eroğlu; Özlem Görükmez; Özlem Solak; Ali Topak; Tahsin Yakut
Journal:  Rheumatol Int       Date:  2015-07-18       Impact factor: 2.631

4.  FOXO3a Alleviates the Inflammation and Oxidative Stress via Regulating TGF-β and HO-1 in Ankylosing Spondylitis.

Authors:  Shanshan Xu; Xiaoyi Zhang; Yubo Ma; Yuting Chen; Huimin Xie; Lingxiang Yu; Jinian Wang; Sheng-Qian Xu; Faming Pan
Journal:  Front Immunol       Date:  2022-06-17       Impact factor: 8.786

5.  The LDL/HDL ratio and atherosclerosis in ankylosing spondylitis.

Authors:  A Kucuk; A Uğur Uslu; A Icli; E Cure; S Arslan; K Turkmen; A Toker; M Kayrak
Journal:  Z Rheumatol       Date:  2017-02       Impact factor: 1.372

6.  Proteomics in rheumatology: the dawn of a new era.

Authors:  Kamala Vanarsa; Chandra Mohan
Journal:  F1000 Med Rep       Date:  2010-12-08

7.  Decreased Oxidative Stress in Male Patients with Active Phase Ankylosing Spondylitis Who Underwent Whole-Body Cryotherapy in Closed Cryochamber.

Authors:  Agata Stanek; Armand Cholewka; Tomasz Wielkoszyński; Ewa Romuk; Aleksander Sieroń
Journal:  Oxid Med Cell Longev       Date:  2018-05-02       Impact factor: 6.543

8.  The Effect of Whole-Body Cryotherapy at Different Temperatures on Proinflammatory Cytokines, Oxidative Stress Parameters, and Disease Activity in Patients with Ankylosing Spondylitis.

Authors:  Anna Straburzyńska-Lupa; Magdalena Paulina Kasprzak; Mateusz Wojciech Romanowski; Anna Kwaśniewska; Wojciech Romanowski; Maria Iskra; Radosław Rutkowski
Journal:  Oxid Med Cell Longev       Date:  2018-10-03       Impact factor: 6.543

9.  Increased Levels of Oxidative Stress Markers, Soluble CD40 Ligand, and Carotid Intima-Media Thickness Reflect Acceleration of Atherosclerosis in Male Patients with Ankylosing Spondylitis in Active Phase and without the Classical Cardiovascular Risk Factors.

Authors:  Agata Stanek; Armand Cholewka; Tomasz Wielkoszyński; Ewa Romuk; Karolina Sieroń; Aleksander Sieroń
Journal:  Oxid Med Cell Longev       Date:  2017-08-15       Impact factor: 6.543

10.  Evaluation of serum thiol/disulfide homeostasis in patients with ankylosing spondylitis by a novel method.

Authors:  Rabia Aydogan Baykara; Ayca Tuzcu; Ahmet Omma; Gunseli Karaca Acet; Erdal Dogan; Almila Aydin; Medine Cumhur Cure; Erkan Cure; Adem Kucuk; Ozcan Erel
Journal:  North Clin Istanb       Date:  2018-08-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.